-+ 0.00%
-+ 0.00%
-+ 0.00%

Canaccord Genuity Maintains Buy on Compass Pathways, Lowers Price Target to $18

Benzinga·03/26/2026 15:05:33
Listen to the news
Canaccord Genuity analyst Sumant Kulkarni maintains Compass Pathways (NASDAQ:CMPS) with a Buy and lowers the price target from $20 to $18.